ClinicalTrials.gov
ClinicalTrials.gov Menu

Circulating Tumor Material in Colorectal Cancer and Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02907086
Recruitment Status : Recruiting
First Posted : September 20, 2016
Last Update Posted : October 8, 2018
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania

Brief Summary:
Observational study to allow the collection of blood and medical information to evaluate the role of circulating tumor material in patients with colorectal cancer and melanoma

Condition or disease Intervention/treatment
Colorectal Cancer and Melanoma Other: blood collection

Study Type : Observational
Estimated Enrollment : 110 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Protocol to Permit the Acquisition of Circulating Tumor Material in Colorectal Cancer and Melanoma
Study Start Date : August 2016
Estimated Primary Completion Date : August 2020

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
colorectal cancer Other: blood collection
melanoma Other: blood collection



Primary Outcome Measures :
  1. Number of blood samples collected [ Time Frame: 24 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
colorectal cancer and melanoma patients
Criteria

Inclusion Criteria:

  • The subject must be a patient at the Hospital of the University of Pennsylvania

    1. Patients with presumed stage II, III, or IV colorectal cancer with planned surgical resection of either the primary tumor or metastatic lesion(s) being evaluated at the Hospital of the University of Pennsylvania
    2. Patients with histologically confirmed melanoma stage IIb, IIc, IIIa, IIIb, or IIIc/IV scheduled for surgical resection being evaluated at the Hospital of the University of Pennsylvania.
  • The subject must be able to provide informed consent or have an acceptable surrogate capable of giving consent on the subject's behalf.
  • The subject must be 18 years of age or older.

Exclusion Criteria:

  • The subject is not able to provide informed consent.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02907086


Contacts
Contact: Mark O'Hara, MD 855-216-0098 PennCancerTrials@emergingmed.com

Locations
United States, Pennsylvania
Abramson Cancer Center of the University of Pennsylvania Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contact: Mark O'Hara, MD    855-216-0098    PennCancerTrials@emergingmed.com   
Principal Investigator: Mark O'Hara, MD         
Sponsors and Collaborators
Abramson Cancer Center of the University of Pennsylvania
Investigators
Principal Investigator: Mark O'Hara, MD Abramson Cancer Center of the University of Pennsylvania

Responsible Party: Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier: NCT02907086     History of Changes
Other Study ID Numbers: UPCC 12916
First Posted: September 20, 2016    Key Record Dates
Last Update Posted: October 8, 2018
Last Verified: October 2018

Additional relevant MeSH terms:
Melanoma
Colorectal Neoplasms
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases